Endo Bag Market Size, Share, Growth, and Industry Analysis, By Type ( Detachable,Non-detachable ), By Application ( Hospitals,Ambulatory Surgical Centers,Nursing Home ), Regional Insights and Forecast to 2035

Endo Bag Market Overview

Global Endo Bag market size is estimated at USD 325.09 million in 2026 and is expected to reach USD 455.64 million by 2035 at a 4.0% CAGR.

The global Endo Bag Market comprises surgical specimen retrieval bags extensively used in minimally invasive procedures such as laparoscopic surgery, robotic assisted surgery, gynecological and general surgery, with total global demand estimated at around USD 414 million in 2025 and expected to reach USD 443 million in 2026 based on supply and volume metrics. Endo bag devices are essential tools used to safely extract tissue, organs, and specimens through small incisions during surgery; worldwide procedural utilization exceeds 35 million laparoscopic procedures annually. Market segmentation shows detachable bags account for approximately 55% share of volume due to ease of use and adaptability in complex specimen retrieval, while non‑detachable bags cover about 45% share of total units distributed. Globally, over 70% of demand originates from hospitals and ambulatory surgical centers because these facilities perform the majority of minimally invasive procedures, with nursing homes contributing the remaining portion of utilization due to outpatient surgical care. Competitive conditions indicate concentration among a few leading manufacturers that collectively capture roughly 60–65% of the market, underscoring industry consolidation and innovation focus.

In the United States, the Endo Bag Market is highly influenced by the extensive use of minimally invasive surgeries, including laparoscopic and robotic procedures, which account for over 25 million procedures annually in U.S. healthcare facilities. The U.S. represents approximately 44% share of global specimen retrieval bag demand due to advanced healthcare infrastructure and high surgical volumes. Johnson & Johnson Services (Ethicon) holds the largest share of U.S. endo bag units supplied, followed closely by Medtronic and CONMED Corporation among key competitors. Hospitals in the U.S. perform the majority of specimen retrieval procedures, with more than 70% of endo bags distributed into hospital surgical departments, while ambulatory surgical centers and nursing homes account for the remainder of utilization.

Download Free Sample to learn more about this report.

Key Findings

• Key Market Driver: Approximately 65% of surgeons prefer endo bags due to safer specimen extraction, driving Endo Bag Market Growth in minimally invasive surgical workflows.
• Major Market Restraint: Around 40% of procurement teams cite the high pricing of advanced specimen containment bags as a major Endo Bag Market restraint in price‑sensitive regions.
• Emerging Trends: About 30% of new products introduced are featuring reinforced seams and leak‑proof closures, highlighting Endo Bag Market Trends toward safer and more reliable surgical retrieval.
• Regional Leadership: North America holds nearly 44% share of the global Endo Bag Market due to high surgical volumes and advanced healthcare infrastructure.
• Competitive Landscape: Top two competitors collectively capture around 35–40% share of the Endo Bag Market Analysis due to established distribution networks and extensive product portfolios.
• Market Segmentation: In segmentation by product type, detachable endo bags comprise around 55% share, while non‑detachable endo bags represent approximately 45% share.
• Recent Development: Over 25% of manufacturers have unveiled eco‑friendly or advanced material endo bags between 2023 and 2025 to enhance procedural safety and sustainability.

Endo Bag Market Latest Trends

The Endo Bag Market Latest Trends reflect significant technological and procedural shifts driven by the rising adoption of minimally invasive surgeries. Surgeons are increasingly performing laparoscopic, gynecological, urological, and colorectal procedures — all of which require specimen containment devices to safely extract tissues or organs through small incisions. In 2025, global surgical volumes for these procedures are estimated at more than 35 million annually, making endo bags essential. Because about 50–55% of all endo bag installations utilize detachable designs, these allow easier placement and removal during complex surgeries. Non‑detachable bags, accounting for around 45% of usage, are still widely used in routine laparoscopic workflows due to surgeon familiarity and cost efficiency.

Endo Bag Market Trends also show rising demand for reinforced and leak‑proof closures, with approximately 30% of recent product launches incorporating these features to improve surgical outcomes. Self‑opening mechanisms and color‑coded variants are also trending as 15% of new offerings introduced between 2023 and 2025. Hospitals represent the largest application segment with an estimated 70% share of unit demand due to high surgical throughput, while ambulatory surgical centers (ASCs) and nursing homes adopt these devices for outpatient procedures. Regional trends indicate that North America accounts for nearly 44% of total market share, followed by Europe and Asia‑Pacific due to advanced healthcare systems and rising procedural volumes. Innovation in material science, such as enhanced polymer bags that resist tearing even under strenuous extraction conditions, is influencing endo bag designs and driving procedural confidence for surgeons worldwide.

Endo Bag Market Dynamics

DRIVER

"Increasing Adoption of Minimally Invasive Surgeries"

The Endo Bag Market Growth is closely linked to the growing global adoption of minimally invasive surgical techniques, especially laparoscopic and robotic assisted surgeries that reduce recovery times and complications compared to open surgery. Over 35 million minimally invasive procedures are performed annually worldwide, with demand for effective specimen retrieval devices increasing accordingly. Endo bags are essential in these procedures to contain tissue, organ parts, or surgical specimens removed from the body through small incisions, helping maintain sterility and reduce contamination risk during extraction. The rising preference for laparoscopic over traditional surgeries, particularly in general surgery, gynecology, and urology, drives significant use of endo bags. Approximately 70% of endo bag deployments occur in hospital operating rooms where surgical volumes are highest, followed by ambulatory surgical centers (about 20%) that perform outpatient procedures. Nursing homes, while smaller volume users at around 10%, increasingly adopt these devices for minor surgical extractions and outpatient care. Continuous advancements in surgical robotics and imaging also encourage surgeons to utilize endo bags, as procedures requiring precision specimen handling become more frequent. As more healthcare providers emphasize patient safety and procedural efficiency, the demand for high‑quality endo bags is expected to expand concomitantly with surgical procedures that necessitate secure specimen retrieval.

RESTRAINT

"High Cost and Procurement Barriers"

A significant restraint in the Endo Bag Market Outlook is the high cost associated with advanced specimen retrieval bags, which can limit adoption in price‑sensitive regions and healthcare settings with limited budgets. Approximately 40% of healthcare procurement teams report that the unit price of premium endo bags — especially those with reinforced seams, leak‑proof features, and specialized ergonomic designs — exceeds budget thresholds in emerging market hospitals and ambulatory surgery centers. This cost factor is particularly salient in developing nations where overall surgical instrument budgets are constrained and essential devices often take priority. In such contexts, hospitals may opt for basic or reprocessed retrieval bags that meet minimum standards but lack advanced features necessary for high‑risk or complex procedures. High unit cost also places procurement pressure on smaller healthcare facilities such as nursing homes and community clinics, which typically handle lower surgical volumes and have less negotiating leverage compared to large hospital chains. With approximately 20–30% of devices purchased in these settings requiring budget approvals and approvals from multiple committees, the HTTPP cost constraint dampens broader market penetration. Cost barriers are further accentuated by the need for compliance with strict regulatory requirements, which can inflate product prices due to lengthy approval processes and added documentation. As a result, revenue growth and share expansion for high‑end endo bag models can be restrained, particularly in markets highly sensitive to purchasing costs and reimbursement structures.

OPPORTUNITY

"Material Innovation and Eco""‑Friendly Solutions"

A key Endo Bag Market Opportunity lies in material innovation and the development of eco‑friendly, biodegradable surgical retrieval bags that meet sustainability goals while enhancing procedural safety. With growing emphasis on reducing medical waste — particularly non‑biodegradable polymer bags that contribute to landfill burden — approximately 20% of new product developments between 2023 and 2025 focus on alternative materials that are biocompatible yet retain strength and durability during extraction. These innovations include reinforced polypropylene blends and biodegradable thermoplastic materials designed to maintain tear‑resistance under surgical stress while degrading more rapidly after disposal. Eco‑friendly endo bags offer competitive advantage in regions where healthcare institutions are adopting corporate sustainability mandates and waste reduction benchmarks. Hospitals often track surgical consumables’ ecological impact; approximately 30% of facilities have set internal objectives to reduce single‑use plastic waste, making biodegradable options desirable. Material innovation also extends to transparent windows, enhancing intraoperative visualization; about 15% of advanced bags incorporate this feature, enabling surgeons to monitor specimen containment in real‑time. These technological opportunities align with broader healthcare trends emphasizing patient safety, environmental responsibility, and operational efficiency, offering manufacturers avenues to differentiate product portfolios and expand adoption in both mature and emerging markets.

CHALLENGE

"Regulatory Compliance and Safety Standards"

A central challenge impacting the Endo Bag Market Forecast is navigating stringent regulatory compliance and surgical safety standards that vary across regions. Device manufacturers must secure approvals from multiple regulatory bodies, which often require extensive testing, documentation, and clinical evidence demonstrating safety and effectiveness. Approximately 50% of endo bag manufacturers report regulatory hurdles that extend product launch timelines, particularly when entering markets with complex approval frameworks such as North America and Europe. These regulatory processes aim to ensure high levels of patient safety and device performance under surgical conditions, but they can also delay access to market for new designs, materials, and innovative features. Ensuring compliance with sterilization standards, biocompatibility requirements, and labeling norms adds complexity and cost to product development cycles. In certain jurisdictions, manufacturers must conduct additional clinical trials specific to local regulatory guidelines, which can involve several thousand device usage instances documented to demonstrate reliability. Maintaining rigorous quality controls during production to meet regulatory benchmarks also increases overhead for suppliers, especially for smaller firms. Balancing regulatory compliance with the need for agile product innovation remains an ongoing challenge that impacts the pace of Endo Bag Market Growth, particularly in high‑barrier markets where certification demands are most rigorous.

Endo Bag Market Segmentation

Download Free Sample to learn more about this report.

The Endo Bag Market segmentation by type and application highlights deployment patterns across surgical retrieval categories. By type, detachable bags account for approximately 55% share due to their adaptability and ease of use during complex laparoscopic procedures, while non‑detachable bags represent about 45% share, appreciated for straightforward reliability in routine operations. By application, hospitals dominate with around 70% market share because they perform the highest volumes of minimally invasive procedures; ambulatory surgical centers contribute about 20% due to outpatient laparoscopic surgeries; nursing homes make up roughly 10% as lower‑volume facilities adopting specimen retrieval tools for minor surgical tasks.

BY TYPE

Detachable Endo Bags: Detachable endo bags represent around 55% share of the Endo Bag Market by type in 2025, driven by their widespread adoption in a variety of minimally invasive procedures where flexibility and ease of handling are critical. These bags allow surgeons to detach the containment unit from the insertion device after specimen placement, enabling smoother extraction of tissue or organs through small incisions in laparoscopic, gynecological, and urological surgeries. Detachable bags are often preferred in complex procedures requiring precision control and secure specimen retrieval, as approximately 60% of advanced laparoscopic workflows incorporate detachable designs to reduce intraoperative manipulation and contamination risk. Hospitals are primary users of detachable bags, as they perform the majority of high‑complexity surgical cases, with ambulatory surgical centers and nursing homes also adopting them for outpatient and minor surgical procedures. Technological improvements such as reinforced seams and ergonomic closures enhance procedural safety and reflect continuous innovation, making detachable endo bags central to overall market volume.

Non‑detachable Endo Bags: Non‑detachable endo bags account for about 45% share of the Endo Bag Market by type in 2025, valued for their simplicity and cost efficiency in routine surgical specimen retrieval. These bags remain connected to the insertion tube until the specimen is fully contained and extracted, providing surgeons with reliable removal solutions during common laparoscopic surgeries. Non‑detachable bags see heavy usage in general surgery procedures where procedural variables are less complex and specimen volumes are moderate. These bags are extensively used in ambulatory surgical centers, representing approximately 25% of non‑detachable deployments, where outpatient surgical volumes and procedural costs are key factors. Hospitals also deploy non‑detachable endo bags widely due to their reliability in standard surgical environments, contributing significantly to overall adoption. The stable market share reflects surgeon trust in established non‑detachable formats, where ease of deployment and familiar handling protocols maintain relevance in both high‑volume and routine surgical settings.

BY APPLICATION

Hospitals: Hospitals constitute the leading application segment in the Endo Bag Market, accounting for approximately 70% share of global demand in 2025 due to the high volume of minimally invasive laparoscopy, general surgery, and specialty procedures performed at these facilities. Endo bags are essential in operating theaters to securely contain and extract specimens such as tissues, organs, or tumors during surgeries. Hospitals handle the vast majority of complex surgical workflows, with millions of laparoscopic procedures conducted annually. The high demand for endo bags in hospitals also reflects regulatory and safety standards that prioritize sterile, single‑use retrieval tools to reduce contamination risk during specimen removal. Surgical departments frequently stock multiple sizes and types of endo bags to support diverse case requirements, ensuring that over 70% of hospital surgical kits include these retrieval devices. Advanced hospitals with robotic surgery capabilities use detachable and reinforced endo bags, contributing to the broader market share captured by this application segment.

Ambulatory Surgical Centers: Ambulatory Surgical Centers (ASCs) account for about 20% of total endo bag usage as of 2025, as these facilities increasingly perform outpatient laparoscopic and minimally invasive procedures. ASCs focus on surgical efficiency, cost management, and patient throughput, making reusable or efficient endo bag formats valuable for routine surgical workflows. These centers typically handle moderate procedural volumes, such as gynecological laparoscopy and minor general surgery cases. The streamlined case mix in ASCs encourages the adoption of both detachable and non‑detachable endo bag types, with procedural protocols tailored to outpatient operational cycles. Though smaller than hospitals in volume, ASCs contribute meaningfully to overall endo bag demand due to their growing role in surgical care delivery outside traditional hospital settings.

Nursing Home: Nursing homes represent approximately 10% share of global endo bag application as of 2025, primarily used in minor surgical or specimen retrieval activities performed onsite or coordinated with visiting surgical teams. These facilities increasingly incorporate procedural tools to support minor interventions, postoperative care, and nursing‑led surgical assistance programs that require specialized containment devices. Nursing homes often stock a limited range of endo bags based on procedural frequency, focusing on cost‑effective and reliable formats suitable for occasional use. As healthcare delivery models shift toward more integrated care within long‑term care settings, nursing homes may gradually increase usage of endo bag devices, but their share remains smaller compared with higher‑volume hospitals and ambulatory centers.

Endo Bag Market Regional Outlook

Download Free Sample to learn more about this report.

The global Endo Bag Market exhibits regional performance differences, with North America holding approximately 44% share, Europe around 29%, Asia‑Pacific around 23%, and Middle East & Africa about 4% of total unit demand in 2025 based on procedural volumes and adoption data.

NORTH AMERICA

North America accounts for the largest share of the global Endo Bag Market, estimated at approximately 44% in 2025, driven by extensive volumes of minimally invasive surgeries and advanced healthcare infrastructure. In the United States alone, millions of laparoscopic and robotic‑assisted procedures are performed annually, forming the core demand base for endo bags and specimen retrieval devices. Key players such as Johnson & Johnson Services (Ethicon) and Medtronic hold substantial regional influence due to established distribution networks, product portfolios, and surgeon preferences for high‑quality devices. Surgical departments in North American hospitals routinely stock multiple sizes and types of endo bags to support varied procedures, contributing to high unit adoption. The region’s strong hospital networks — with over 6,000 acute care hospitals in the U.S. alone — use endo bags extensively for tissue containment during both routine and complex surgeries. Ambulatory surgical centers (ASCs) are also significant contributors, representing approximately 25% of endo bag demand in the region, as outpatient surgical volumes accelerate due to healthcare cost optimization initiatives. North America’s regulatory environment emphasizes device safety and procedural outcomes, encouraging the adoption of advanced and certified endo bags with reinforced materials and ergonomic design. The high volume of surgical procedures combined with technology adoption readiness underpins the region’s leading share in the Endo Bag Market Outlook.

EUROPE

Europe represents approximately 29% of the global Endo Bag Market Share in 2025, supported by well‑established healthcare systems and comprehensive training programs promoting minimally invasive surgical techniques. Countries like Germany, the United Kingdom, and France are significant contributors, accounting for a majority of regional demand due to high procedural volumes and tight clinical guidelines that recommend safe specimen retrieval devices. European healthcare facilities leverage endo bags for general surgery, laparoscopic procedures, and gynecological operations, with Germany reporting more than 18% growth in minimally invasive surgeries between 2022 and 2023, which drives device utilization and procedural adoption. Hospitals in Europe allocate a substantial portion of surgical kits to specimen retrieval tools, with nearly 60% of kits including endo bags for a variety of surgical applications. Ambulatory surgical centers and specialty clinics form smaller segments, contributing to approximately 20% of regional usage, particularly in private healthcare settings where outpatient procedures are increasing. European regulatory frameworks such as the Medical Device Regulation (MDR) influence device quality standards and ensure that endo bags deployed in surgeries meet stringent safety requirements. This environment enhances clinician confidence and reinforces endo bag adoption across advanced surgical applications.

ASIA‑PACIFIC

The Asia‑Pacific region accounts for around 23% share of the global Endo Bag Market in 2025 as healthcare infrastructure expands and surgical volumes increase in countries like China, Japan, India, and Australia. Rising investments in minimally invasive surgery equipment, growing patient awareness of laparoscopic procedure benefits, and expanding public and private healthcare facilities contribute to demand in the region. Surgical procedure rates — particularly for general surgery and gynecological laparoscopy — have increased by over 15% year‑over‑year in key Asia‑Pacific markets, stimulating greater use of endo bags for specimen containment. Hospitals in urban centers lead endo bag adoption, with ambulatory surgical centers and specialty clinics contributing around 20% of demand for minimally invasive devices. Asia‑Pacific also shows rising interest in cost‑effective device options due to budget considerations, encouraging adoption of reliable but lower‑cost endo bag formats. Continued infrastructure upgrades and expansions in surgical capacity are expected to sustain market share growth in the region.

MIDDLE EAST & AFRICA

The Middle East & Africa region holds about 4% share of global endo bag demand in 2025, with adoption driven by expanding healthcare infrastructure and increasing volumes of minimally invasive procedures in countries such as Saudi Arabia, South Africa, and the United Arab Emirates. Hospitals in this region incorporate endo bags into surgical protocols as part of standard specimen retrieval practices, particularly for laparoscopic and general surgery cases, albeit at lower volumes compared to developed regions. Ambulatory surgical centers and specialty clinics contribute modestly to adoption due to smaller procedural volumes and healthcare spending constraints. Ongoing investments in surgical facilities and training continue to create opportunities for increased endo bag utilization, positioning the Middle East & Africa for gradual market expansion.

List of Top Endo Bag Companies

• Johnson & Johnson
• Teleflex Incorporated
• Applied Medical Resources Corporation
• CONMED Corporation
• Cooper Surgical
• Genicon
• Braun Melsungen
• Laprosurge
• Purple Surgical
• Medtronic

Top 2 Companies with Highest Market Share

• Johnson & Johnson (Ethicon): A recognized leader in the Endo Bag Market, with approximately 15–18% share of global specimen retrieval bag units supplied due to extensive product offerings and surgeon familiarity.
• Teleflex Incorporated: A major competitor holding around 10–12% share, known for its surgical retrieval devices and global distribution penetration.

Investment Analysis and Opportunities

Investment in the Endo Bag Market is aligning with broader trends in surgical instrumentation and minimally invasive technologies. As hospitals and healthcare providers perform more than 35 million laparoscopic surgeries annually, investment opportunities are being directed toward innovative device formats, material enhancements, and manufacturing scale‑up to meet procedural demand. A significant portion of recent investment — nearly 30% of research initiatives — focuses on developing bags with reinforced seams, leak‑proof closures, and transparent body windows that support intraoperative visualization and reduce sample contamination risks. These improvements enhance device reliability and surgeon appeal, creating opportunities for differentiated product lines.

Another opportunity lies in expanding distribution networks across Asia‑Pacific and Middle Eastern healthcare markets, where surgical capacity and minimally invasive procedure volumes are increasing rapidly. Strategic partnerships with local distributors and healthcare systems offer pathways to scale unit penetration in emerging economies. As demand for advanced specimen retrieval devices continues to grow, combining innovation, distribution, and clinical support programs presents viable investment opportunities for market entrants and existing players alike.

New Product Development

New product development within the Endo Bag Market is focused on enhancing surgical efficiency, safety, and usability. A growing share of product launches — around 30% of recent releases between 2023 and 2025 — feature reinforced seams and leak‑proof closure mechanisms that significantly improve specimen containment integrity during laparoscopic procedures. These advanced structural features address key surgeon needs by preventing rupture or leakage even when handling larger tissue volumes or fragile specimens. Some new products also incorporate transparent windows that allow direct visualization of the specimen within the bag, aiding precise control and confirmation of retrieval before removal from the surgical site.

Biodegradable material options are emerging, with around 20% of new products utilizing bio‑based components that support environmental sustainability mandates in hospitals and surgical centers. These bags provide comparable strength to conventional polymer bags while aligning with waste reduction objectives. Collectively, these new product developments enhance clinical outcomes, expand application versatility, and offer surgeons more reliable and user‑friendly tools, reinforcing the overall Endo Bag Market Outlook.

Five Recent Developments

• In 2023, approximately 25% of endo bag manufacturers unveiled new reinforced seam designs to improve specimen containment reliability in advanced laparoscopic procedures.
• In 2024, about 20% of product launches featured transparent visualization windows to allow surgeons to monitor specimen placement within the bag intraoperatively.
• In 2024, detachably handle‑designed endo bags increased in adoption by roughly 15% due to ergonomic deployment advantages.
• In 2025, biodegradable polymer endo bags were introduced in approximately 20% of product portfolios to address healthcare sustainability mandates.
• In 2025, manufacturers expanded distribution into over 30 new markets globally, enhancing accessibility of endo bags in emerging regions.

Report Coverage of Endo Bag Market

The Endo Bag Market Report provides a comprehensive view of the global landscape for specimen retrieval devices used in surgical procedures. It covers segmentation by product type, highlighting that detachable bags account for approximately 55% share while non‑detachable bags make up about 45% share of overall units deployed in 2025, each tailored to specific surgical workflows and clinician preferences. Application analysis details that hospitals represent around 70% of usage, with ambulatory surgical centers at 20% and nursing homes at 10%, reflecting how endo bags are distributed across diverse healthcare settings. The regional analysis elucidates that North America holds roughly 44% share, Europe about 29%, Asia‑Pacific around 23%, and Middle East & Africa about 4% of global demand due to variations in surgical volumes, healthcare infrastructure, and minimally invasive procedure adoption rates as of 2025.